Should You Investigate Li & Fung Limited (HKG:494) At HK$1.15?

Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card!

Li & Fung Limited (HKG:494), which is in the luxury business, and is based in Hong Kong, saw significant share price movement during recent months on the SEHK, rising to highs of HK$1.55 and falling to the lows of HK$1.15. Some share price movements can give investors a better opportunity to enter into the stock, and potentially buy at a lower price. A question to answer is whether Li & Fung’s current trading price of HK$1.15 reflective of the actual value of the small-cap? Or is it currently undervalued, providing us with the opportunity to buy? Let’s take a look at Li & Fung’s outlook and value based on the most recent financial data to see if there are any catalysts for a price change.

See our latest analysis for Li & Fung

Is Li & Fung still cheap?

The stock seems fairly valued at the moment according to my relative valuation model. In this instance, I’ve used the price-to-earnings (PE) ratio given that there is not enough information to reliably forecast the stock’s cash flows. I find that Li & Fung’s ratio of 9.52x is trading slightly below its industry peers’ ratio of 9.64x, which means if you buy Li & Fung today, you’d be paying a fair price for it. And if you believe that Li & Fung should be trading at this level in the long run, then there’s not much of an upside to gain from mispricing. Although, there may be an opportunity to buy in the future. This is because Li & Fung’s beta (a measure of share price volatility) is high, meaning its price movements will be exaggerated relative to the rest of the market. If the market is bearish, the company’s shares will likely fall by more than the rest of the market, providing a prime buying opportunity.

Can we expect growth from Li & Fung?

SEHK:494 Past and Future Earnings, June 1st 2019
SEHK:494 Past and Future Earnings, June 1st 2019

Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Buying a great company with a robust outlook at a cheap price is always a good investment, so let’s also take a look at the company’s future expectations. Li & Fung’s earnings over the next few years are expected to increase by 36%, indicating a highly optimistic future ahead. This should lead to more robust cash flows, feeding into a higher share value.

What this means for you:

Are you a shareholder? It seems like the market has already priced in 494’s positive outlook, with shares trading around its fair value. However, there are also other important factors which we haven’t considered today, such as the financial strength of the company. Have these factors changed since the last time you looked at 494? Will you have enough confidence to invest in the company should the price drop below its fair value?

Are you a potential investor? If you’ve been keeping tabs on 494, now may not be the most optimal time to buy, given it is trading around its fair value. However, the optimistic forecast is encouraging for 494, which means it’s worth further examining other factors such as the strength of its balance sheet, in order to take advantage of the next price drop.

Price is just the tip of the iceberg. Dig deeper into what truly matters – the fundamentals – before you make a decision on Li & Fung. You can find everything you need to know about Li & Fung in the latest infographic research report. If you are no longer interested in Li & Fung, you can use our free platform to see my list of over 50 other stocks with a high growth potential.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.